These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Prognosis
13 results:

  • 1. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a ttd and GECOP-SEOQ expert consensus statement.
    Grávalos C; Pereira F; Vera R; Arjona-Sánchez A; Losa F; Ramos I; García-Alfonso P; Gonzalez-Bayón L; Cascales-Campos PA; Aranda E
    Clin Transl Oncol; 2023 Dec; 25(12):3378-3394. PubMed ID: 37140736
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SEOM-GEMCAD-ttd clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).
    Fernández Montes A; Alonso V; Aranda E; Élez E; García Alfonso P; Grávalos C; Maurel J; Vera R; Vidal R; Aparicio J
    Clin Transl Oncol; 2023 Sep; 25(9):2718-2731. PubMed ID: 37133732
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
    Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
    World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tumour location and efficacy of first-line EGFR inhibitors in
    Benavides M; Díaz-Rubio E; Carrato A; Abad A; Guillén C; Garcia-Alfonso P; Gil S; Cano MT; Safont MJ; Gravalos C; Manzano JL; Sánchez A; Alcaide J; López R; Massutí B; Sastre J; Martínez E; Escudero P; Méndez M; Aranda E
    ESMO Open; 2019; 4(6):e000599. PubMed ID: 31803504
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon cancer.
    Gao Z; Fu P; Yu Z; Zhen F; Gu Y
    Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development of a Correlative Strategy To Discover colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
    Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
    Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates colorectal Carcinogenesis and prognosis.
    Liu J; Li H; Sun L; Feng X; Wang Z; Yuan Y; Xing C
    Biomed Res Int; 2018; 2018():9651320. PubMed ID: 29568775
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. colorectal cancer Carcinogenesis: a Multivariate Genetic Model in a Cohort of Romanian Population.
    Procopciuc LM; Osian G; Iancu M
    Clin Lab; 2017 Apr; 63(4):647-658. PubMed ID: 28397463
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
    Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
    Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association between polymorphisms of XRCC1 Arg399Gln and xpd Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.
    Gan Y; Li XR; Chen DJ; Wu JH
    Asian Pac J Cancer Prev; 2012; 13(11):5721-4. PubMed ID: 23317245
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Relationship between single nucleotide polymorphism in repair gene xpd751 and prognosis in colorectal carcinoma patients].
    Chen YM; Wu XL; Zhang LW; Xu X; Liu JW
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):501-5. PubMed ID: 22967467
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.
    Moreno V; Gemignani F; Landi S; Gioia-Patricola L; Chabrier A; Blanco I; González S; Guino E; Capellà G; Canzian F
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2101-8. PubMed ID: 16609022
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Implications of genetic testing in the management of colorectal cancer.
    Stoehlmacher J; Lenz HJ
    Am J Pharmacogenomics; 2003; 3(2):73-88. PubMed ID: 12749725
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.